ARCHIVES

In Brief: Hatch Bill Would Require NDA Sponsors To Pay Fee; IND, Generic Drug NDAs Would Be Exempt

This article is from The Cancer Letter archive.

Vol. 12 No. 34 | August 22, 1986

Download PDF Visit The Full Archive

Related Articles

NCI Begins Phase III Trial Of Shark Cartilage In NSCLC.

May 25, 2001

DePinho’s Handling Of MD Anderson Tenure Dispute Triggers Formal Investigation by AAUP

July 18, 2014

NCI Programs: Genetic Variations Discovered, Added to NCI Database

June 11, 1999

Guest Editorial: Andrew Vickers on PSA Skepticism, Rational and Irrational

October 10, 2014

Construction Not Dead After All; DCPC Board Okays Architect/ Engineering Support Contract

February 13, 1987

NCI Advisors: Resume Prevention Trial, Add Edometrial Sampling

May 13, 1994